Copyright: ©Author(s) 2026.
World J Gastrointest Endosc. Jun 16, 2026; 18(6): 117354
Published online Jun 16, 2026. doi: 10.4253/wjge.v18.i6.117354
Published online Jun 16, 2026. doi: 10.4253/wjge.v18.i6.117354
Table 2 Clinical advantages and appropriate indications of cryoballoon ablation
| Potential advantages | Appropriate indications | Lesions unsuitable for CBA |
| Depth-limited uniform injury (reduced perforation risk) | Benign non-ampullary duodenal adenomas (Paris 0-IIa/IIb) | Bulky circumferential lesions (> 5 cm) |
| Preservation of submucosal collagen matrix | Recurrent or fibrotic (non-lifting) lesions | Suspected deep submucosal invasion |
| Non-thermal mechanism avoiding coagulative necrosis | Residual adenoma within scar tissue or near clips | Lesions requiring histologic margin assessment |
| Technically simple balloon-based delivery system | Lesions in angulated or technically challenging locations |
- Citation: Seo JY, Yoo JH. Expanding the therapeutic spectrum for duodenal adenomas: Cryoballoon ablation. World J Gastrointest Endosc 2026; 18(6): 117354
- URL: https://www.wjgnet.com/1948-5190/full/v18/i6/117354.htm
- DOI: https://dx.doi.org/10.4253/wjge.v18.i6.117354